ArticleFrontiers in oncology2025

Treatment of relapsed or refractory Hodgkin's lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review.

Hongjuan Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.